vs
Side-by-side financial comparison of CuriosityStream Inc. (CURI) and LIFECORE BIOMEDICAL, INC. \DE\ (LFCR). Click either name above to swap in a different company.
LIFECORE BIOMEDICAL, INC. \DE\ is the larger business by last-quarter revenue ($31.1M vs $19.2M, roughly 1.6× CuriosityStream Inc.). CuriosityStream Inc. runs the higher net margin — -19.7% vs -32.1%, a 12.4% gap on every dollar of revenue. On growth, CuriosityStream Inc. posted the faster year-over-year revenue change (35.8% vs -4.5%). CuriosityStream Inc. produced more free cash flow last quarter ($3.9M vs $25.0K). Over the past eight quarters, CuriosityStream Inc.'s revenue compounded faster (26.5% CAGR vs -0.1%).
Curiosity Stream Inc., formerly branded as CuriosityStream, is an American media company and over-the-top subscription video streaming service which offers documentary programming including films, series, and TV shows. The company offers a video on demand subscription service branded as "Curiosity Stream" and a linear broadcast television channel known as the Curiosity Channel through various services including FuboTV and The Roku Channel.
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
CURI vs LFCR — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $19.2M | $31.1M |
| Net Profit | $-3.8M | $-10.0M |
| Gross Margin | — | 25.0% |
| Operating Margin | -17.6% | -9.9% |
| Net Margin | -19.7% | -32.1% |
| Revenue YoY | 35.8% | -4.5% |
| Net Profit YoY | -34.6% | -52.0% |
| EPS (diluted) | $-0.07 | $-0.29 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $19.2M | — | ||
| Q3 25 | $18.4M | $31.1M | ||
| Q2 25 | $19.0M | — | ||
| Q1 25 | $15.1M | $35.2M | ||
| Q4 24 | $14.1M | $32.6M | ||
| Q3 24 | $12.6M | $24.7M | ||
| Q2 24 | $12.4M | — | ||
| Q1 24 | $12.0M | $35.7M |
| Q4 25 | $-3.8M | — | ||
| Q3 25 | $-3.7M | $-10.0M | ||
| Q2 25 | $784.0K | — | ||
| Q1 25 | $319.0K | $-14.8M | ||
| Q4 24 | $-2.8M | $-6.6M | ||
| Q3 24 | $-3.1M | $-16.2M | ||
| Q2 24 | $-2.0M | — | ||
| Q1 24 | $-5.0M | $15.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | 25.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 28.0% | ||
| Q4 24 | — | 34.0% | ||
| Q3 24 | — | 21.8% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 33.3% |
| Q4 25 | -17.6% | — | ||
| Q3 25 | -24.5% | -9.9% | ||
| Q2 25 | 2.5% | — | ||
| Q1 25 | 0.5% | -25.7% | ||
| Q4 24 | -27.4% | -6.0% | ||
| Q3 24 | -25.8% | -46.9% | ||
| Q2 24 | -20.6% | — | ||
| Q1 24 | -30.4% | -2.5% |
| Q4 25 | -19.7% | — | ||
| Q3 25 | -20.4% | -32.1% | ||
| Q2 25 | 4.1% | — | ||
| Q1 25 | 2.1% | -42.0% | ||
| Q4 24 | -19.9% | -20.2% | ||
| Q3 24 | -24.3% | -65.7% | ||
| Q2 24 | -16.4% | — | ||
| Q1 24 | -42.0% | 43.8% |
| Q4 25 | $-0.07 | — | ||
| Q3 25 | $-0.06 | $-0.29 | ||
| Q2 25 | $0.01 | — | ||
| Q1 25 | $0.01 | $-0.47 | ||
| Q4 24 | $-0.05 | $-0.25 | ||
| Q3 24 | $-0.06 | $-0.53 | ||
| Q2 24 | $-0.04 | — | ||
| Q1 24 | $-0.09 | $0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $27.3M | $18.9M |
| Total DebtLower is stronger | — | $136.0M |
| Stockholders' EquityBook value | $41.5M | $-10.5M |
| Total Assets | $75.7M | $235.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $27.3M | — | ||
| Q3 25 | $27.8M | $18.9M | ||
| Q2 25 | $28.1M | — | ||
| Q1 25 | $33.4M | $5.4M | ||
| Q4 24 | $32.1M | $9.5M | ||
| Q3 24 | $33.2M | — | ||
| Q2 24 | $39.5M | — | ||
| Q1 24 | $38.8M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | $136.0M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $124.9M | ||
| Q4 24 | — | $111.3M | ||
| Q3 24 | — | $106.3M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $97.1M |
| Q4 25 | $41.5M | — | ||
| Q3 25 | $47.2M | $-10.5M | ||
| Q2 25 | $49.8M | — | ||
| Q1 25 | $58.1M | $2.2M | ||
| Q4 24 | $57.8M | $15.4M | ||
| Q3 24 | $62.2M | $-3.9M | ||
| Q2 24 | $64.8M | — | ||
| Q1 24 | $67.0M | $17.7M |
| Q4 25 | $75.7M | — | ||
| Q3 25 | $74.7M | $235.2M | ||
| Q2 25 | $78.7M | — | ||
| Q1 25 | $85.3M | $237.7M | ||
| Q4 24 | $86.2M | $255.4M | ||
| Q3 24 | $87.6M | $246.8M | ||
| Q2 24 | $90.9M | — | ||
| Q1 24 | $94.6M | $246.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 56.05× | ||
| Q4 24 | — | 7.20× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 5.49× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $4.0M | $1.8M |
| Free Cash FlowOCF − Capex | $3.9M | $25.0K |
| FCF MarginFCF / Revenue | 20.5% | 0.1% |
| Capex IntensityCapex / Revenue | 0.1% | 5.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-16.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.0M | — | ||
| Q3 25 | $4.4M | $1.8M | ||
| Q2 25 | $2.8M | — | ||
| Q1 25 | $1.9M | $1.2M | ||
| Q4 24 | $3.0M | $-6.1M | ||
| Q3 24 | $2.3M | $-613.0K | ||
| Q2 24 | $2.2M | — | ||
| Q1 24 | $666.0K | $-1.4M |
| Q4 25 | $3.9M | — | ||
| Q3 25 | — | $25.0K | ||
| Q2 25 | — | — | ||
| Q1 25 | $1.8M | $-4.3M | ||
| Q4 24 | — | $-8.6M | ||
| Q3 24 | — | $-4.0M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $-7.8M |
| Q4 25 | 20.5% | — | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | — | ||
| Q1 25 | 12.2% | -12.1% | ||
| Q4 24 | — | -26.3% | ||
| Q3 24 | — | -16.3% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -21.8% |
| Q4 25 | 0.1% | — | ||
| Q3 25 | 0.0% | 5.6% | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.5% | 15.5% | ||
| Q4 24 | 0.0% | 7.5% | ||
| Q3 24 | 0.0% | 13.9% | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.0% | 17.8% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 3.56× | — | ||
| Q1 25 | 6.03× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -0.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CURI
Segment breakdown not available.
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
